Cellectar Biosciences Inc (CLRB) — Financial Flexibility Index
Cellectar Biosciences Inc (CLRB) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-4.34 Million (operating CF $-4.34 Million minus capex $5.88K) represents -1% of total liabilities ($5.06 Million). Check Cellectar Biosciences Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cellectar Biosciences Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Cellectar Biosciences Inc across 22 annual periods. See Cellectar Biosciences Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cellectar Biosciences Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Cellectar Biosciences Inc. For the full company profile including market capitalisation, see Cellectar Biosciences Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.57x | $-23.11 Million | $-23.12 Million | $5.06 Million | ▼ -7.6% |
| 2024 | -4.25x | $-47.48 Million | $-47.58 Million | $11.18 Million | ▼ -248.4% |
| 2023 | -1.22x | $-31.51 Million | $-32.38 Million | $25.85 Million | ▲ +41.2% |
| 2022 | -2.07x | $-25.00 Million | $-25.22 Million | $12.05 Million | ▲ +61.6% |
| 2021 | -5.40x | $-22.43 Million | $-22.57 Million | $4.16 Million | ▼ -50.3% |
| 2020 | -3.59x | $-13.87 Million | $-13.93 Million | $3.86 Million | ▲ +1.8% |
| 2019 | -3.66x | $-11.67 Million | $-11.69 Million | $3.19 Million | ▲ +40.7% |
| 2018 | -6.17x | $-11.06 Million | $-11.44 Million | $1.79 Million | ▼ -22.3% |
| 2017 | -5.04x | $-10.67 Million | $-11.02 Million | $2.12 Million | ▼ -9.6% |
| 2016 | -4.60x | $-8.21 Million | $-8.28 Million | $1.78 Million | ▼ -235.5% |
| 2015 | -1.37x | $-8.15 Million | $-8.21 Million | $5.95 Million | ▲ +58.4% |
| 2014 | -3.30x | $-8.81 Million | $-8.84 Million | $2.67 Million | ▼ -87.2% |
| 2013 | -1.76x | $-9.01 Million | $-9.15 Million | $5.12 Million | ▲ +64.2% |
| 2012 | -4.92x | $-6.49 Million | $-6.59 Million | $1.32 Million | ▲ +9.1% |
| 2011 | -5.41x | $-5.85 Million | $-5.97 Million | $1.08 Million | ▲ +13.1% |
| 2010 | -6.22x | $-7.80 Million | $-7.80 Million | $1.25 Million | ▼ -2003.5% |
| 2009 | -0.30x | $-10.60 Million | $-10.62 Million | $35.83 Million | ▲ +87.9% |
| 2008 | -2.45x | $-17.28 Million | $-17.33 Million | $7.05 Million | ▼ -209.6% |
| 2007 | -0.79x | $-13.44 Million | $-13.47 Million | $16.98 Million | ▲ +83.9% |
| 2006 | -4.92x | $-6.46 Million | $-6.47 Million | $1.31 Million | ▲ +55.0% |
| 2005 | -10.93x | $-2.37 Million | $-2.40 Million | $217.16K | ▼ -12417.6% |
| 2004 | -0.09x | $-389.17K | $-389.18K | $4.46 Million | — |